Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
25/08/26	€0.1530	-1.29%	76,741
24/08/26	€0.1550	+0.65%	149,638
21/08/26	€0.1540	-0.39%	186,390
20/08/26	€0.1546	+0.39%	511,475
19/08/26	€0.1540	+0.79%	75,301

Real-time Euronext Paris

More quotes

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris 16:55:00 25/08/2026 BST			5-day change	1st Jan Change
0.1530 ^EUR	-1.29%		+0.13%	-30.14%

08-11	Klea Holding SA Reports Unaudited Consolidated Sales Results for the first half of 2026	CI
07-29	EQT to sell Quantios to Vista Equity Partners	FW

Market Cap	46.97M 54.81M 44.01M 40.2M 75.87M 5.23B 76.62M 519M 202M 2.64B 206M 201M 8.73B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	47.09M 54.96M 44.13M 40.31M 76.07M 5.24B 76.82M 521M 203M 2.64B 206M 202M 8.75B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

08-11	Klea Holding SA Reports Unaudited Consolidated Sales Results for the first half of 2026	CI
07-29	EQT to sell Quantios to Vista Equity Partners	FW
07-15	Klea Holding targets improved profitability in the second half
06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
03-31	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
01-19	Klea Holding Increases Annual Revenue by 28%
01-19	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
01-19	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI

07-15	Klea : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	PU
07-15	Klea Holding : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	AT
06-11	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
04-23	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
04-23	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT

Klea Holding Share Price

Stocks

ALKLH

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news : Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Course Extremes

Managers and Directors: Klea Holding

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

08-17	Klea : Déclaration des transactions sur actions propres
08-17	Klea Holding : Déclaration des transactions sur actions propres
07-27	Klea Holding : Déclaration des transactions sur actions propres
07-20	Klea Holding : Déclaration des transactions sur actions propres
07-15	Klea Holding vise une amélioration de sa rentabilité au second semestre

1 day	-1.29%
1 week	+0.13%
Current month	-2.05%
1 month	-3.16%
3 months	-19.47%
6 months	-30.93%
Current year	-30.14%

1 week	0.15	0.16
1 month	0.15	0.16
Current year	0.15	0.25
1 year	0.15	0.31
3 years	0.15	0.43
5 years	0.08	0.59
10 years	0.08	149.6

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	21/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	31/03/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	31/03/2022
Paul Amsellem BRD	Director/Board Member	51	13/06/2023

Date	Insider	Type	Quantity	% Market Cap.
17/07/26	Raphael Smila	Buy	103,000	0.0335%
17/07/26	Raphael Smila	Buy	103,000	0.0335%
16/07/26	Raphael Smila	Buy	87,000	0.0283%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	-1.29%	+0.13%	-28.17%	-64.10%	55.52M
CVS HEALTH CORPORATION	-1.29%	-2.12%	+30.46%	+38.00%	120B
HCA HEALTHCARE, INC.	-0.11%	+4.14%	+6.45%	+56.89%	92.93B
FRESENIUS SE & CO. KGAA	-0.42%	-1.89%	-3.12%	+56.25%	30.26B
QUEST DIAGNOSTICS INCORPORATED	+0.26%	+3.50%	+36.86%	+84.69%	26.92B
TENET HEALTHCARE CORPORATION	-2.41%	+0.62%	+50.85%	+266.27%	22.43B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.13%	+1.86%	-1.67%	-5.61%	22.19B
REDE D'OR SÃO LUIZ S.A.	+4.49%	+9.94%	-3.94%	+23.49%	14.64B
FRESENIUS MEDICAL CARE AG	+0.15%	-0.88%	-7.52%	-8.94%	12.46B
DAVITA INC.	+0.74%	-0.06%	+29.47%	+76.72%	11.26B
Average	+0.28%	+1.10%	+10.97%	+52.37%	35.35B
Weighted average by Cap.	+0.18%	+0.86%	+18.23%	+58.79%

	2024	2025
Net sales	17.26M 20.14M 16.17M 14.77M 27.88M 1.92B 28.16M 191M 74.26M 969M 75.63M 73.98M 3.21B	22.17M 25.87M 20.77M 18.97M 35.8M 2.47B 36.16M 245M 95.37M 1.24B 97.13M 95.01M 4.12B
Net income	1.4M 1.64M 1.32M 1.2M 2.27M 156M 2.29M 15.53M 6.05M 78.86M 6.16M 6.02M 261M	2.28M 2.66M 2.14M 1.95M 3.68M 254M 3.72M 25.21M 9.81M 128M 9.99M 9.78M 424M
Net Debt	2.58M 3.01M 2.41M 2.2M 4.16M 286M 4.2M 28.46M 11.08M 145M 11.28M 11.04M 479M	125K 146K 117K 107K 202K 13.91M 204K 1.38M 538K 7.02M 548K 536K 23.24M